Yıl: 2018 Cilt: 44 Sayı: 4 Sayfa Aralığı: 294 - 297 Metin Dili: İngilizce DOI: 10.5152/tud.2018.46666 İndeks Tarihi: 17-01-2019

Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study

Öz:
Objective: In this study, we aimed to evaluate the efficacy of tadalafil in the management of erectile dysfunctionin patients under dutasteride medication for bladder outlet obstruction.Material and methods: In this study the data of consecutive patients that admitted to our outpatient clinicstreated with dutasteride for bladder outlet obstruction and tadalafil (10 or 20 mg on demand) for concomitantcomplaint of erectile dysfunction (ED) between October 2013 and March 2016 were evaluated. An agematchedcontrol group of patients treated with tadalafil for ED but did not receive any other medication foreither lower urinary tract symptoms (LUTS) or ED was also included. Groups were compared for tadalafilefficacy with International Index of Erectile Function (IIEF) scores.Results: Each one of the dutasteride and control groups included 104 patients. The groups were similar forpretreatment IIEF score, serum cholesterol, low-density lipoprotein (LDL), triglyceride and testosterone measurements.The number of hypertensive patients was comparable between two groups but the number of diabeticpatients were significantly higher in the control group. IIEF score improved significantly in both groupsfollowing tadalafil treatment but the difference between the two groups was not statistically significant.Conclusion: Tadalafil treatment provides significant improvement in erectile functions of patients underdutasteride treatment for bladder outlet obstruction. However, the current study does not focus on a populationof dutasteride induced ED and therefore a further prospective study on this issue would be helpful
Anahtar Kelime:

Konular: Üroloji ve Nefroloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, et al. The ENDOTRIAL study: a spontaneous, openlabel, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med 2009;6:2547-60. [Crossref]
  • Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G, Aria A, et al. Efficacy and safety of a dual inhibitor of 5-alphareductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002;60:434-41. [Crossref]
  • Glina S, Roehrborn CG, Esen A, Plekhanov A, Sorsaburu S, Henneges C, et al. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, doubleblind, placebo-controlled study of tadalafil coadministered with finasteride. J Sex Med 2015;12:129-38. [Crossref]
  • Hakky TS, Jain L. Current use of phosphodiesterase inhibitors in urology. Turk J Urol 2015;41:88-92. [Crossref]
  • Curran M, Keating G. Tadalafil. Drugs 2003;63:2203-14. [Crossref]
  • Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. BMJ 2016;354:i4823. [Crossref]
  • Liu L, Zhao S, Li F, Li E, Kang R, Luo L, et al. Effect of 5alpha- Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. J Sex Med 2016;13:1297-310. [Crossref]
  • McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793-803. [Crossref]
  • Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU Guidelines on the Assessment of Nonneurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol 2015;67:1099-109. [Crossref]
  • Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab 2004;89:2179-84. [Crossref]
APA ÖZKIDIK M, GÖKCE M, YAMAN M (2018). Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. , 294 - 297. 10.5152/tud.2018.46666
Chicago ÖZKIDIK Mete,GÖKCE Mehmet İlker,YAMAN MUHİDDİN ÖNDER Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. (2018): 294 - 297. 10.5152/tud.2018.46666
MLA ÖZKIDIK Mete,GÖKCE Mehmet İlker,YAMAN MUHİDDİN ÖNDER Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. , 2018, ss.294 - 297. 10.5152/tud.2018.46666
AMA ÖZKIDIK M,GÖKCE M,YAMAN M Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. . 2018; 294 - 297. 10.5152/tud.2018.46666
Vancouver ÖZKIDIK M,GÖKCE M,YAMAN M Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. . 2018; 294 - 297. 10.5152/tud.2018.46666
IEEE ÖZKIDIK M,GÖKCE M,YAMAN M "Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study." , ss.294 - 297, 2018. 10.5152/tud.2018.46666
ISNAD ÖZKIDIK, Mete vd. "Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study". (2018), 294-297. https://doi.org/10.5152/tud.2018.46666
APA ÖZKIDIK M, GÖKCE M, YAMAN M (2018). Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. Turkish Journal of Urology, 44(4), 294 - 297. 10.5152/tud.2018.46666
Chicago ÖZKIDIK Mete,GÖKCE Mehmet İlker,YAMAN MUHİDDİN ÖNDER Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. Turkish Journal of Urology 44, no.4 (2018): 294 - 297. 10.5152/tud.2018.46666
MLA ÖZKIDIK Mete,GÖKCE Mehmet İlker,YAMAN MUHİDDİN ÖNDER Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. Turkish Journal of Urology, vol.44, no.4, 2018, ss.294 - 297. 10.5152/tud.2018.46666
AMA ÖZKIDIK M,GÖKCE M,YAMAN M Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. Turkish Journal of Urology. 2018; 44(4): 294 - 297. 10.5152/tud.2018.46666
Vancouver ÖZKIDIK M,GÖKCE M,YAMAN M Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study. Turkish Journal of Urology. 2018; 44(4): 294 - 297. 10.5152/tud.2018.46666
IEEE ÖZKIDIK M,GÖKCE M,YAMAN M "Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study." Turkish Journal of Urology, 44, ss.294 - 297, 2018. 10.5152/tud.2018.46666
ISNAD ÖZKIDIK, Mete vd. "Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study". Turkish Journal of Urology 44/4 (2018), 294-297. https://doi.org/10.5152/tud.2018.46666